We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Immunodiagnostic Systems Holdings Plc | LSE:IDH | London | Ordinary Share | GB00B01YZ052 | ORD 2P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 378.00 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
TIDMIDH
RNS Number : 3431M
Immunodiagnostic Systems Hldgs PLC
27 July 2017
Results of AGM
Immunodiagnostic Systems Holdings PLC
27 July 2017
Immunodiagnostic Systems Holdings plc
Results of AGM
Immunodiagnostic Systems Holdings PLC ("the Company"), a specialist producer of manual and automated diagnostic testing kits and instruments for the clinical market, announces the results of its Annual General Meeting (the "Meeting") that was held at 2pm today.
Trading Update
At the meeting the Chairman, Dr Burkhard Wittek, provided a business update. A copy of the statement has been made available on the Company's website.
Voting Results
All resolutions put to the Meeting were decided on a show of hands and all were duly passed.
For information, details of the proxy voting are shown below:
Resolution Votes For Votes For Votes Against Votes Withheld (as % of (as % of votes cast) votes cast) ---------------------------------- ----------- ------------- -------------- --------------- 1. To receive the accounts for the year ended 31 March 2017 together with the report of the Directors and of the Auditor thereon. 14,124,207 100% 0.00% 0 ---------------------------------- ----------- ------------- -------------- --------------- 2. To declare a final dividend for the year ended 31 March 2017. 14,124,207 100% 0.00% 0 ---------------------------------- ----------- ------------- -------------- --------------- 3. To elect as a director of the Company Mr Regis Jacques Duval. 14,118,287 100% 0.00% 5,300 ---------------------------------- ----------- ------------- -------------- --------------- 4. To re-appoint Ernst & Young LLP as Auditor of the Company. 14,124,207 100% 0.00% 0 ---------------------------------- ----------- ------------- -------------- --------------- 5. To authorize the Directors of the Company to determine the remuneration of the Auditor of the Company. 14,124,207 100% 0.00% 0 ---------------------------------- ----------- ------------- -------------- --------------- 6. To approve the Directors' Remuneration Report for the financial year ended 31 March 2017. 14,118,237 99.96% 0.04% 50 ---------------------------------- ----------- ------------- -------------- --------------- 7. To authorise the Directors to allot relevant securities. 14,124,207 100% 0.00% 0 ---------------------------------- ----------- ------------- -------------- --------------- 8. To authorise the disapplication of pre-emption rights in accordance with section 570 of the Companies Act 2006. 14,109,207 99.89% 0.11% 0 ---------------------------------- ----------- ------------- -------------- --------------- 9. To authorise the Directors to make market purchases. 14,123,607 100% 0.00% 0 ---------------------------------- ----------- ------------- -------------- ---------------
The full text of each of the resolutions is set out in the notice of Annual General Meeting, copies of which are available on the IDS website (www.idsplc.com).
For further information:
Immunodiagnostic Systems Holdings plc Tel : +44 (0)191 5190660
Paul Martin, Group Finance Director
Peel Hunt LLP Tel : +44 (0)207 418 8900
James Steel
Oliver Jackson
This information is provided by RNS
The company news service from the London Stock Exchange
END
RAGSELFLWFWSELW
(END) Dow Jones Newswires
July 27, 2017 10:45 ET (14:45 GMT)
1 Year Immunodiagnostic Systems Chart |
1 Month Immunodiagnostic Systems Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions